Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in InventoryChange in TaxesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InflaRx (IFRX) Short-Term Debt repayments (2022 - 2025)

Historic Short-Term Debt repayments for InflaRx (IFRX) over the last 4 years, with Q3 2025 value amounting to -$99314.7.

  • InflaRx's Short-Term Debt repayments rose 685.9% to -$99314.7 in Q3 2025 from the same period last year, while for Sep 2025 it was -$422271.9, marking a year-over-year decrease of 115.62%. This contributed to the annual value of -$420070.6 for FY2024, which is 439.73% down from last year.
  • As of Q3 2025, InflaRx's Short-Term Debt repayments stood at -$99314.7, which was up 685.9% from -$112977.5 recorded in Q2 2025.
  • Over the past 5 years, InflaRx's Short-Term Debt repayments peaked at -$91831.6 during Q3 2022, and registered a low of -$115600.7 during Q2 2024.
  • In the last 4 years, InflaRx's Short-Term Debt repayments had a median value of -$101915.0 in 2022 and averaged -$101758.3.
  • The largest annual percentage gain for InflaRx's Short-Term Debt repayments in the last 5 years was 746.54% (2024), contrasted with its biggest fall of 1659.96% (2024).
  • InflaRx's Short-Term Debt repayments (Quarter) stood at -$93187.3 in 2022, then fell by 9.57% to -$102108.9 in 2023, then dropped by 2.53% to -$104689.2 in 2024, then rose by 5.13% to -$99314.7 in 2025.
  • Its Short-Term Debt repayments stands at -$99314.7 for Q3 2025, versus -$112977.5 for Q2 2025 and -$105290.5 for Q1 2025.